LABU

Direxion Daily S&P Biotech Bull …

• Seeking Alpha·18h ago

  The Trump Administration's Affordability Plan

• Seeking Alpha·5d ago

  Leveraged ETF Watchlist And Focus On SPXU History

• Seeking Alpha·02/26 11:56

  Q1 Active Management Pulse: Positioning Broadens Beyond AI Leaders

• Seeking Alpha·02/01 17:05

  Measuring UDOW's Drift, And Leveraged ETF Watchlist

• Seeking Alpha·01/29 04:50

  The Diversification Role Mid-Cap Stocks Can Play

• Seeking Alpha·01/26 14:19

  LABD: ETF To Benefit From Downturns In The Biotech Industry

• Seeking Alpha·01/22 11:07

  Are Healthcare Stocks Poised To Recover As Policy Fears Stabilize?

• Seeking Alpha·01/20 17:39

  CURE: Benefits And Caveats Of The Leveraged Healthcare ETF

• NASDAQ·01/15 16:46

  Notable ETF Outflow Detected - LABU, RVMD, MRNA, KRYS

• Seeking Alpha·01/08 10:30

  Healthcare Stocks In Focus: Assessing The Outlook For 2026

• Seeking Alpha·01/02 15:04

  Leveraged ETF Drift Watch List And Focus On SQQQ

• Seeking Alpha·12/19/2025 08:10

  Key Takeaways From Equity Earnings Calls: Q3 2025

• Benzinga·12/18/2025 13:30

  Navigate Biotech's Crosscurrents With Direxion's LABU And LABD ETFs

• Seeking Alpha·12/17/2025 17:29

  LABU: The Risks And Rewards Of A Leveraged Biotechnology ETF

• Seeking Alpha·12/03/2025 06:00

  SEC warns Direxion, ProShares, and Tidal, stalling new leveraged ETF launches